Study Evaluates MRI Risks for Pacemaker and Defibrillator Patients
Overview of the Study
A recent study published in the New England Journal of Medicine examined the risks linked to MRI procedures in patients with pacemakers or implantable cardioverter-defibrillators (ICDs). The findings indicate that the dangers associated with temporarily removing these devices outweigh the risks of conducting an MRI scan while keeping the devices in place.
Understanding Cardiovascular Devices
Pacemakers and ICDs are commonly used in individuals with heart disease to monitor and manage abnormal heart rhythms. Pacemakers treat arrhythmias by delivering a low level of electrical impulses to maintain a normal heart rate. In contrast, ICDs are implanted under the skin to continuously monitor the heart rate, delivering shocks when an irregular rate is detected to restore normalcy.
Magnetic Resonance Imaging Explained
MRI is a widely utilized imaging technique that employs magnetic fields and radio waves to create detailed images of internal organs, bones, and tissues. Initially, patients with pacemakers and ICDs were advised against MRI scans due to concerns that the magnetic field could heat cardiac leads—thin wires in the heart—potentially causing thermal injuries or disrupting the device’s pacing capabilities.
Advancements in Device Technology
Over the past two decades, improvements in device design have significantly reduced the risks associated with MRI. Many devices are now classified as “MRI-conditional,” indicating that they pose no known hazards during MRI procedures. However, approximately 6 million individuals globally still have devices that do not meet MRI-conditional criteria, with an expectation that half of these patients will require an MRI at some point.
The MagnaSafe Registry
To address these concerns, the MagnaSafe registry was established to track participants and monitor their health and devices after undergoing non-thoracic MRI scans (thoracic scans were excluded due to heightened risk) at a magnetic field strength of 1.5 tesla. The study included 1,500 participants—1,000 with pacemakers and 500 with ICDs—all over the age of 18 and having non-conditional MRI devices implanted after 2001.
Study Protocol and Findings
The research adhered to a stringent protocol for device interrogation, programming, patient monitoring, and follow-up to ensure safety. Devices were assessed before and after the MRI, with participants monitored for critical outcomes such as death during the procedure, immediate device failures necessitating replacement, and instances of induced arrhythmia. Notably, none of the patients experienced death or device lead failures, although six patients did experience arrhythmias lasting less than 49 hours.
Conclusion and Implications
The study’s limitations include a diverse participant population with varying devices from different manufacturers and multiple MRI scans for some individuals. Ultimately, the authors conclude that the risks associated with removing a pacemaker or ICD likely surpass those of conducting an MRI scan while the device remains in place. They also propose a protocol for the procedure and monitoring of patients with cardiac devices requiring MRI scans.